You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 21, 2025

Drug Price Trends for PODOFILOX


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for PODOFILOX

Average Pharmacy Cost for PODOFILOX

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
PODOFILOX 0.5% GEL 00574-0621-05 119.69988 GM 2024-12-18
PODOFILOX 0.5% TOPICAL SOLN 00574-0611-05 14.06371 ML 2024-12-18
PODOFILOX 0.5% GEL 00574-0621-05 132.56364 GM 2024-11-20
PODOFILOX 0.5% TOPICAL SOLN 00574-0611-05 13.25592 ML 2024-11-20
PODOFILOX 0.5% GEL 00574-0621-05 128.94238 GM 2024-11-13
PODOFILOX 0.5% TOPICAL SOLN 00591-3204-13 17.62952 ML 2024-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Podofilox

Market Overview

Podofilox, a topical keratolytic drug, is widely used for the treatment of genital warts, which are caused by the Human Papillomavirus (HPV). Here is a comprehensive analysis of the market and price projections for podofilox.

Global Genital Warts Treatment Market

The global genital warts treatment market, in which podofilox is a key player, is expected to grow significantly over the next few years. The market size is projected to increase from USD 1.91 billion in 2024 to USD 2.72 billion by 2031, exhibiting a CAGR of 5.2% during the forecast period[4].

Market Share and Drug Type Analysis

In the genital warts treatment market, podofilox competes with other drugs such as imiquimod, trichloroacetic acid, and others. Imiquimod currently leads the market with a 38% share, but podofilox remains a significant player due to its efficacy in treating genital warts[3].

Price Projections for Podofilox

Current Pricing

As of the latest data, the cost for podofilox topical 0.5% gel is around $591 for a 3.5-gram supply, and for the 0.5% topical solution, it is approximately $43.41 for 3.5 milliliters. These prices are subject to variation based on the pharmacy and location[2].

Future Pricing Trends

Given the growing demand for genital warts treatments and the increasing prevalence of HPV infections, the prices of podofilox and similar medications may see fluctuations. Here are some key factors that could influence pricing:

  • Increasing Demand: The rising number of HPV infections and the growing awareness about sexually transmitted diseases are expected to drive the demand for podofilox, potentially leading to stable or slightly increased prices[4].
  • Competition: The presence of other treatment options like imiquimod and trichloroacetic acid could keep prices competitive. However, podofilox's established market presence and efficacy may help maintain its pricing structure[3].
  • Healthcare Infrastructure: Improvements in healthcare infrastructure in emerging nations could lead to higher demand and potentially higher prices due to increased access to these medications[4].

Distribution Channels and Market Dynamics

Distribution Channels

Podofilox is primarily distributed through hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies currently hold the largest market share, with 49% of the genital warts treatment market[3].

Market Dynamics

  • Drivers: The market growth for podofilox is driven by increasing awareness about HPV and genital warts, the availability of effective treatments, and growing healthcare infrastructure in emerging nations[4].
  • Restraints: High treatment costs, social stigma associated with genital warts, and preferences for non-drug therapies can hamper market growth. Additionally, logistical issues and the need for cold storage for vaccines can complicate the delivery of related treatments[4][5].

Regional Insights

Global Market

The global genital warts treatment market is dominated by North America, which holds around 38% of the market share. This is due to the high prevalence of HPV infections and the well-developed healthcare infrastructure in the region[3].

Asia-Pacific

The Asia-Pacific region, particularly countries like China and India, is expected to see significant growth due to urbanization, industrialization, and increasing healthcare spending. This region is anticipated to contribute substantially to the overall growth of the podofilox market[1].

Medical Applications and Usage

Medical Uses

Podofilox is commonly used to treat genital warts (condylomata acuminata) and is part of the topical keratolytics drug class. It is also used in various other medical applications, including as a vesicant, purgative, antirheumatic, antiviral, and antitumor agent[2].

Usage Trends

The growing demand for podofilox in treating HPV infections and other medical conditions is expected to drive market growth. The product is often applied under the supervision of healthcare professionals to control side effects, which underscores its importance in clinical settings[1].

Key Takeaways

  • Market Growth: The genital warts treatment market, which includes podofilox, is expected to grow at a CAGR of 5.2% from 2024 to 2031.
  • Pricing: Current prices for podofilox range from $43.41 for a 3.5ml solution to $591 for a 3.5g gel, with potential for stable or slightly increased prices due to growing demand.
  • Distribution: Hospital pharmacies dominate the distribution channels, holding 49% of the market share.
  • Regional Insights: North America leads the market, but the Asia-Pacific region is expected to see significant growth.
  • Medical Applications: Podofilox is crucial in treating genital warts and has various other medical uses.

FAQs

What is the current market size of the genital warts treatment market?

The global genital warts treatment market is estimated to be valued at USD 1.91 billion in 2024[4].

What is the projected CAGR for the genital warts treatment market?

The market is expected to grow at a CAGR of 5.2% from 2024 to 2031[4].

What are the primary distribution channels for podofilox?

Podofilox is primarily distributed through hospital pharmacies, retail pharmacies, and online pharmacies[3].

What are the main drivers of the podofilox market?

The market is driven by increasing awareness about HPV, the availability of effective treatments, and growing healthcare infrastructure in emerging nations[4].

How much does a typical supply of podofilox cost?

A 3.5-gram supply of podofilox 0.5% gel costs around $591, and a 3.5ml supply of the 0.5% solution costs approximately $43.41[2].

Sources

  1. Business Research Insights: Podophyllin Market Size | 2024 To 2032 Analysis Report
  2. Drugs.com: Podofilox topical Prices, Coupons, Copay Cards & Patient Assistance
  3. Market.US: Genital Warts Treatment Market Size, Share | CAGR of 4.9%
  4. Coherent Market Insights: Genital Warts Treatment Market - Price, Size, Share & Growth
  5. GlobeNewswire: Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.